Compare Global X Lithium & Battery Tech ETF (LIT) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X Lithium & Battery Tech ETF vs Oscar Health Inc — how do they compare? Global X Lithium & Battery Tech ETF trades at $69.73 (market cap $1.45B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Oscar Health Inc is far larger — about 7× Global X Lithium & Battery Tech ETF's market cap, and Oscar Health Inc is trading nearer its 52-week high, Global X Lithium & Battery Tech ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X Lithium & Battery Tech ETF for 56 Days and Oscar Health Inc for 15 Days on average.
| LIT | OSCR | |
|---|---|---|
Market Cap | $1.45B | $10.22B |
Volume | 89,392 | 4,123,394 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $91.62 | $33.81 |
52-Week Low | $53.92 | $10.85 |
Typical Hold Time | 56 Days | 15 Days |
Enterprise Value | — | $6.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LIT trades at $69.73, up 0.32% with mixed technical signals showing a bullish overall trend but bearish moving averages and oscillators. The ETF's price action remains volatile, trading near key support/resistance levels. Recent news highlights significant short interest reduction and ongoing exposure to the lithium and battery technology sector, which faces both supply chain challenges and long-term growth potential from electric vehicle adoption.
The outlook for LIT is cautiously optimistic, driven by global EV adoption trends and energy storage demand, though tempered by lithium price volatility and competitive pressures. Key risks include commodity price swings and geopolitical factors affecting battery supply chains, while institutional sentiment shows mixed signals with technical indicators suggesting near-term consolidation.
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global X Lithium & Battery Tech ETF
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
